Menu
GeneBe

SRP72

signal recognition particle 72, the group of Signal recognition particle|Tetratricopeptide repeat domain containing

Basic information

Region (hg38): 4:56467616-56503681

Links

ENSG00000174780NCBI:6731OMIM:602122HGNC:11303Uniprot:O76094AlphaFoldGenCCjaxSfariGnomADPubmedClinVar

Phenotypes

GenCC

Source: genCC

  • acute myeloid leukemia (Moderate), mode of inheritance: AD
  • autosomal dominant aplasia and myelodysplasia (Limited), mode of inheritance: AD
  • autosomal dominant aplasia and myelodysplasia (Supportive), mode of inheritance: AD
  • autosomal dominant aplasia and myelodysplasia (Strong), mode of inheritance: AD

Clinical Genomic Database

Source: CGD

ConditionInheritanceIntervention CategoriesIntervention/Rationale Manifestation CategoriesReferences
Bone marrow failure syndrome 1ADAudiologic/Otolaryngologic; Hematologic; OncologicIndividuals have been described as having early-onset anemia/panyctopenia, as well as later myelodysplasia, and measures to detect and ameliorate hematologic findings may be beneficial; Early recognition and treatment of hearing impairment may improve outcomes, including speech and language developmentAudiologic/Otolaryngologic; Hematologic; Oncologic22541560

ClinVar

This is a list of variants' phenotypes submitted to ClinVar and linked to the SRP72 gene.

  • not provided (391 variants)
  • Autosomal dominant aplasia and myelodysplasia (78 variants)
  • not specified (49 variants)
  • Inborn genetic diseases (20 variants)
  • SRP72-related condition (9 variants)

Variants pathogenicity by type

Statistics on ClinVar variants can assist in determining whether a specific variant type in the SRP72 gene is commonly pathogenic or not.

In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.

Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.

Variant type Pathogenic Likely pathogenic VUS Likely benign Benign Sum
synonymous
6
clinvar
59
clinvar
7
clinvar
72
missense
166
clinvar
4
clinvar
2
clinvar
172
nonsense
5
clinvar
5
start loss
0
frameshift
8
clinvar
8
inframe indel
3
clinvar
3
splice donor/acceptor (+/-2bp)
4
clinvar
4
splice region
7
11
1
19
non coding
31
clinvar
67
clinvar
66
clinvar
164
Total 0 0 223 130 75

Variants in SRP72

This is a list of pathogenic ClinVar variants found in the SRP72 region.

You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.

Position Type Phenotype Significance ClinVar
4-56467626-C-T Autosomal dominant aplasia and myelodysplasia • SRP72-related disorder Conflicting classifications of pathogenicity (Aug 03, 2020)1803128
4-56467642-A-G Autosomal dominant aplasia and myelodysplasia Uncertain significance (Jan 12, 2018)904205
4-56467644-C-T SRP72-related disorder Likely benign (Jul 14, 2022)3050359
4-56467652-G-C Uncertain significance (Sep 15, 2022)2001809
4-56467653-C-T Likely benign (Jun 24, 2022)1938027
4-56467653-C-CG SRP72-related disorder Uncertain significance (Dec 01, 2023)1723735
4-56467654-G-A Uncertain significance (Sep 27, 2022)2189018
4-56467654-G-C not specified Uncertain significance (Oct 06, 2023)436864
4-56467654-G-T Autosomal dominant aplasia and myelodysplasia Benign (Jan 26, 2024)349112
4-56467655-G-A Autosomal dominant aplasia and myelodysplasia • not specified Conflicting classifications of pathogenicity (Jan 25, 2024)349113
4-56467655-G-C not specified • Autosomal dominant aplasia and myelodysplasia Benign/Likely benign (Feb 01, 2024)377137
4-56467655-G-T SRP72-related disorder Uncertain significance (Oct 14, 2023)2068186
4-56467656-G-A not specified Likely benign (Dec 30, 2023)1337488
4-56467656-G-C not specified Likely benign (Dec 20, 2023)1336014
4-56467656-G-T Autosomal dominant aplasia and myelodysplasia Benign (Feb 01, 2024)349114
4-56467657-G-A Uncertain significance (Oct 01, 2022)2654770
4-56467657-G-C Uncertain significance (Mar 15, 2023)1314214
4-56467658-G-A Autosomal dominant aplasia and myelodysplasia • not specified Conflicting classifications of pathogenicity (Dec 19, 2023)349115
4-56467658-G-C Uncertain significance (May 27, 2023)1020162
4-56467659-G-A Likely benign (Dec 11, 2023)1589529
4-56467659-G-T Likely benign (Nov 01, 2022)2891770
4-56467659-GG-T Uncertain significance (Nov 14, 2022)2502092
4-56467660-G-A SRP72-related disorder Uncertain significance (Dec 21, 2023)2879586
4-56467660-G-C Uncertain significance (Jan 25, 2024)2061158
4-56467660-G-T Uncertain significance (Apr 15, 2023)2980555

GnomAD

Source: gnomAD

GeneTypeBio TypeTranscript Coding Exons Length
SRP72protein_codingprotein_codingENST00000342756 1936759
pLI Probability
LOF Intolerant
pRec Probability
LOF Recessive
Individuals with
no LOFs
Individuals with
Homozygous LOFs
Individuals with
Heterozygous LOFs
Defined p
0.001710.9981257140341257480.000135
Z-Score Observed Expected Observed/Expected Mutation Rate Total Possible in Transcript
Missense1.022943470.8460.00001744381
Missense in Polyphen6593.6230.694271285
Synonymous0.9481081210.8900.000005821232
Loss of Function4.131341.80.3110.00000211512

LoF frequencies by population

EthnicitySum of pLOFs p
African & African-American0.0005190.000518
Ashkenazi Jewish0.0001990.000198
East Asian0.0001730.000163
Finnish0.00004630.0000462
European (Non-Finnish)0.0001340.000132
Middle Eastern0.0001730.000163
South Asian0.00006550.0000653
Other0.0001650.000163

dbNSFP

Source: dbNSFP

Function
FUNCTION: Signal-recognition-particle assembly has a crucial role in targeting secretory proteins to the rough endoplasmic reticulum membrane. Binds the 7S RNA only in presence of SRP68. This ribonucleoprotein complex might interact directly with the docking protein in the ER membrane and possibly participate in the elongation arrest function.;
Disease
DISEASE: Bone marrow failure syndrome 1 (BMFS1) [MIM:614675]: An autosomal dominant disease characterized by aplastic anemia and myelodysplasia resulting from bone marrow failure. Aplastic anemia is a form of anemia in which the bone marrow fails to produce adequate numbers of peripheral blood elements. Myelodysplasia is a clonal hematopoietic stem cell disorder in which immature cells in the bone marrow become malformed and dysfunctional. {ECO:0000269|PubMed:22541560}. Note=The disease is caused by mutations affecting the gene represented in this entry.;
Pathway
Protein export - Homo sapiens (human);SRP-dependent cotranslational protein targeting to membrane;Translation;Metabolism of proteins (Consensus)

Recessive Scores

pRec
0.137

Intolerance Scores

loftool
0.482
rvis_EVS
-0.6
rvis_percentile_EVS
18.06

Haploinsufficiency Scores

pHI
0.739
hipred
Y
hipred_score
0.602
ghis
0.680

Essentials

essential_gene_CRISPR
N
essential_gene_CRISPR2
E
essential_gene_gene_trap
E
gene_indispensability_pred
E
gene_indispensability_score
0.896

Gene Damage Prediction

AllRecessiveDominant
MendelianMediumMediumMedium
Primary ImmunodeficiencyMediumMediumMedium
CancerMediumMediumMedium

Mouse Genome Informatics

Gene name
Srp72
Phenotype

Gene ontology

Biological process
SRP-dependent cotranslational protein targeting to membrane;SRP-dependent cotranslational protein targeting to membrane, translocation;response to drug
Cellular component
endoplasmic reticulum;signal recognition particle, endoplasmic reticulum targeting;cytosol;signal recognition particle
Molecular function
RNA binding;signal recognition particle binding;protein binding;7S RNA binding;TPR domain binding;ribosome binding